Sobre Artivion, Inc. Common Stock Visão geral da empresa da Wikipedia

Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.

Ler mais

Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.

## History

Artivion was founded as CryoLife in Sarasota, Florida in 1984 by Steven Anderson and Robert McNally. Anderson acted as the company’s president and CEO from its founding. The company later moved from Sarasota to the Atlanta metropolitan area. In January 2022 the company changed its name to Artivion, Inc.

In 2000, CryoLife began offering a surgical adhesive called BioGlue used for sealing surgical lacerations under high pressure, such as in arteries.

In February 2008, the FDA gave CryoLife approval for a new kind of heart valve, made from human tissues, which was the first to remove cells from the transplant tissue as opposed to only cleaning the tissue. In giving the approval, the FDA said the new valve, called the CryoValve SynerGraft Pulmonary Valve, had less of a chance of rejection than previous valves.

In 2010, CryoLife acquired the rights to manufacture and distribute PerClot, an absorbable hemostatic powder used in surgery.

In January 2016, the company acquired On-X Life Technologies and its principal product, a mechanical heart valve called the On-X aortic valve replacement, for $130 million.

In October 2017, Artivion acquired JOTEC GmbH, a German-based developer of medical devices for aortic and peripheral vascular diseases, for €225 million. In September 2020, the company acquired Ascyrus Medical.

In 2021, the company received FDA premarket application approval of its PerClot absorbable hemostatic system, which comprised PerClot granules and a delivery system for surgical use. Baxter International agreed to buy PerClot from Artivion in 2021. In 2023, after final FDA approval of the product, the purchase was completed.

Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗

Wikidata ↗

AORT Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas

Preço

$28.89

Capitalização de Mercado

$1.44B

P/E (TTM)

139.4

EPS (TTM)

$0.21

Receita (TTM)

$441M

Rendimento div.

—

ROE

2.2%

Dívida/Capital

0.5

Intervalo 52 Semanas

$19 – $48

AORT Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização

Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS

Receita e Lucro Líquido $441M

2016-12-31 → 2025-12-31

EPS $0.21

2016-12-31 → 2025-12-31

Fluxo de caixa livre $839.0K

2016-12-31 → 2025-12-31

Margens 2.2%

2016-12-31 → 2025-12-31

Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?

Métrica

Tendência de 5 anos

AORT

Mediana de Pares

P/E (TTM)

139.4

38.5

P/S (TTM)

3.3

2.5

P/B

3.2

4.8

EV / EBITDA

28.4

—

Price / FCF (Preço / FCF)

1720.8

—

Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC

Métrica

Tendência de 5 anos

AORT

Mediana de Pares

Gross Margin (Margem Bruta)

64.4%

58.7%

Operating Margin (Margem Operacional)

7.6%

—

Net Profit Margin (Margem de Lucro Líquido)

2.2%

-12.6%

ROA

1.2%

-11.8%

ROE

2.2%

-37.7%

ROIC

3.4%

—

Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial

Métrica

Tendência de 5 anos

AORT

Mediana de Pares

Debt / Equity (Dívida / Patrimônio Líquido)

0.5

25.5

Current Ratio (Índice de liquidez corrente)

3.5

Quick Ratio (Índice de Liquidez Seca)

1.5

—

Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos

Métrica

Tendência de 5 anos

AORT

Mediana de Pares

Revenue YoY (Receita Ano a Ano)

13.6%

—

Revenue CAGR 3Y (CAGR Receita 3A)

12.0%

—

Revenue CAGR 5Y (CAGR Receita 5A)

11.8%

—

Métricas por Ação EPS, valor patrimonial por ação, fluxo de caixa por ação, dividendo por ação

Métrica

Tendência de 5 anos

AORT

Mediana de Pares

EPS (Diluted) (EPS (Diluído))

$0.21

—

Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber

Métrica

Tendência de 5 anos

AORT

Mediana de Pares

Dividendos Rendimento, índice de pagamento, histórico de dividendos, CAGR de 5 anos

Dividend Yield

—

Índice de Pagamento

—

CAGR Dividendos 5 anos

—

Data ex	Valor
9 de Dezembro de 2015	$0,0300
9 de Setembro de 2015	$0,0300
10 de Junho de 2015	$0,0300
11 de Março de 2015	$0,0300
10 de Dezembro de 2014	$0,0300
10 de Setembro de 2014	$0,0300
11 de Junho de 2014	$0,0300
12 de Março de 2014	$0,0280
11 de Dezembro de 2013	$0,0280
11 de Setembro de 2013	$0,0280
12 de Junho de 2013	$0,0280
12 de Março de 2013	$0,0250
12 de Dezembro de 2012	$0,0250
12 de Setembro de 2012	$0,0250

AORT Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta

COMPRA 14 analistas

Compra forte 5 35,7%
Compra 8 57,1%
Manter 1 7,1%
Venda 0 0,0%
Venda forte 0 0,0%

Preço-alvo de 12 meses

8 analistas · 2026-08-18

Mediana $42.00

← Abaixo de todos os alvos $28.89

Mín $38.00

Máx $48.00

Alvo mediano $42.00 +45,4%

Alvo médio $42.15 +45,9%

Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados

Surpresa Média

-0.02%

Período	EPS Actual	EPS est.	Surpresa
30 de Junho de 2026	$-0.28	$0.01	-0.29%
31 de Março de 2026	$0.03	$0.05	-0.02%
31 de Dezembro de 2025	$0.05	$0.08	-0.03%
30 de Setembro de 2025	$0.06	$0.02	0.04%
30 de Junho de 2025	$0.08	$-0.00	0.08%
31 de Março de 2025	$-0.01	$-0.12	0.11%

Comparação de pares (subindústria GICS) Métricas chave vs pares do setor

Ticker	Capitalização de Mercado	P/E	Receita YoY	Margem Líquida	ROE	Margem Bruta
AORT	$2.25B	217.2	13.6%	2.2%	2.2%	64.4%
TNDM	$1.50B	-7.2	7.9%	-20.2%	-141.9%	53.8%
CNMD	$1.27B	26.9	5.2%	3.4%	4.6%	54.6%
ATEC	$3.16B	-21.9	24.9%	-18.8%	-792.1%	69.6%
ENOV	$1.52B	-1.3	6.7%	-52.7%	-58.5%	59.8%
IART	—	-1.8	1.5%	-31.6%	-49.6%	—
KMTS	$1.21B	-8.5	59.0%	-138.4%	-62.1%	51.4%
PRCT	$1.77B	-18.3	37.2%	-31.0%	-25.4%	63.7%
IRMD	$1.24B	55.6	14.4%	26.8%	23.8%	76.8%
ABT	$250.18B	33.7	5.7%	14.7%	13.1%	—

Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa

Demonstração de Resultados 18

Dados anuais de Demonstração de Resultados para AORT
Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$441M	$389M	$354M	$314M	$299M	$253M	$276M	$263M	$190M	$180M	$146M	$145M
Cost of Revenue	$157M	$140M	$125M	$111M	$101M	$85M	$93M	$90M	$61M	$61M	$55M	$53M
Gross Profit	$284M	$249M	$229M	$203M	$198M	$168M	$183M	$173M	$129M	$119M	$91M	$91M
R&D Expense	$31M	$28M	$29M	$39M	$36M	$24M	$23M	$23M	$19M	$13M	$10M	$9M
SG&A Expense	$226M	$181M	$209M	$157M	$170M	$141M	$143M	$141M	$101M	$92M	$75M	$74M
Operating Expenses	$257M	$210M	$238M	$196M	$205M	$165M	$166M	$164M	$121M	$105M	$85M	$82M
Operating Income	$34M	$39M	$6M	$6M	$8M	$2M	$17M	$9M	$8M	$22M	$5M	$9M
Interest Expense	·	·	$25M	$18M	$17M	$17M	$15M	$16M	$5M	$3M	$62.0K	$175.0K
Interest Income	$763.0K	$1M	$1M	$147.0K	$79.0K	$217.0K	$738.0K	$226.0K	$212.0K	$72.0K	$45.0K	$50.0K
Other Non-op	$10M	$-10M	$-3M	$-3M	$-6M	$-3M	$-1M	$-141.0K	$260.0K	$-437.0K	$-484.0K	$-540.0K
Pretax Income	$15M	$-8M	$-22M	$-15M	$-15M	$-17M	$2M	$-6M	$4M	$18M	$6M	$9M
Income Tax	$5M	$6M	$9M	$4M	$7.0K	$-492.0K	$-76.0K	$-4M	$-143.0K	$8M	$2M	$1M
Net Income	$10M	$-13M	$-31M	$-19M	$-15M	$-17M	$2M	$-3M	$4M	$11M	$4M	$7M
EPS (Basic)	$0.22	$-0.32	$-0.75	$-0.48	$-0.38	$-0.44	$0.05	$-0.08	$0.11	$0.33	$0.14	$0.26
EPS (Diluted)	$0.21	$-0.32	$-0.75	$-0.48	$-0.38	$-0.44	$0.05	$-0.08	$0.11	$0.32	$0.14	$0.25
Shares (Basic)	45,335,000	41,676,000	40,743,000	40,032,000	38,983,000	37,861,000	37,118,000	36,412,000	33,008,000	31,855,000	27,744,000	27,379,000
Shares (Diluted)	47,162,000	41,676,000	40,743,000	40,032,000	38,983,000	37,861,000	37,860,000	36,412,000	34,163,000	32,822,000	28,542,000	28,313,000
EBITDA	$56M	$63M	$29M	$29M	$32M	$23M	$35M	$27M	$18M	$30M	·	$15M

Balanço Patrimonial 28

Dados anuais de Balanço Patrimonial para AORT
Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	$65M	$53M	$59M	$39M	$55M	$61M	$34M	$41M	$40M	$57M	$38M	$33M
Receivables	$90M	$79M	$72M	$62M	$53M	$46M	$53M	$47M	$48M	$28M	$23M	$21M
Inventory	$92M	$80M	$82M	$74M	$77M	$73M	$53M	$45M	$47M	$26M	$15M	$13M
Prepaid Expense	$43M	$19M	$16M	$18M	$15M	$14M	$12M	$7M	$5M	$3M	$5M	$5M
Current Assets	$358M	$290M	$281M	$247M	$248M	$235M	$187M	$179M	$179M	$147M	$110M	$106M
PP&E (Net)	$65M	$36M	$38M	$39M	$38M	$33M	$32M	$31M	$34M	$19M	$11M	$12M
PP&E (Gross)	·	·	·	$127M	$120M	$111M	$103M	$96M	$93M	$74M	$64M	$62M
Accum. Depreciation	·	·	·	$88M	$82M	$78M	$71M	$65M	$60M	$55M	$53M	$50M
Goodwill	$254M	$241M	$247M	$244M	$250M	$260M	$187M	$189M	$188M	$78M	$11M	$11M
Intangibles	$124M	$128M	$143M	$151M	$167M	$186M	$115M	$118M	$130M	$1M	$1M	$2M
Other Non-current Assets	$15M	$24M	$9M	$7M	$8M	$15M	$14M	$8M	$7M	$2M	$6M	$5M
Total Assets	$885M	$789M	$792M	$763M	$793M	$789M	$606M	$571M	$590M	$316M	$181M	$176M
Accounts Payable	$16M	$18M	$13M	$12M	$10M	$10M	$10M	$8M	$10M	$6M	$5M	$4M
Accrued Liabilities	$16M	$12M	$10M	$12M	$8M	$7M	$7M	$7M	$12M	$5M	$3M	$3M
Current Liabilities	$102M	$67M	$58M	$50M	$45M	$60M	$45M	$35M	$43M	$30M	$20M	$21M
Capital Leases	$34M	$40M	$44M	$41M	$45M	$14M	$18M	$0	$7M	$11.0K	·	·
Deferred Tax	$24M	$20M	$22M	$24M	$29M	$35M	$26M	$27M	$30M	$7.0K	·	·
Other Non-current Liabilities	$9M	$8M	$7M	$7M	$6M	$7M	$7M	$7M	$8M	$5M	$3M	$3M
Total Liabilities	$437M	$513M	$511M	$478M	$492M	$461M	$320M	$296M	$313M	$107M	$26M	$27M
Long-term Debt	$215M	$314M	$307M	$308M	$309M	$292M	$216M	$217M	$219M	$72M	·	·
Total Debt	$215M	$314M	$307M	$308M	$309M	$292M	$216M	$217M	$219M	$72M	·	·
Common Stock	$493.0K	$434.0K	$426.0K	$418.0K	$414.0K	$404.0K	$390.0K	$385.0K	$376.0K	$342.0K	$298.0K	$292.0K
Retained Earnings	$-51M	$-61M	$-48M	$-17M	$2M	$20M	$37M	$35M	$38M	$34M	$23M	$23M
Treasury Stock	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$13M	$12M	$11M	$9M
AOCI	$-3M	$-25M	$-12M	$-22M	$-10M	$7M	$-9M	$-6M	$2M	$-429.0K	$-76.0K	$-121.0K
Stockholders' Equity	$448M	$276M	$282M	$284M	$301M	$329M	$286M	$275M	$277M	$209M	$155M	$149M
Liabilities + Equity	$885M	$789M	$792M	$763M	$793M	$789M	$606M	$571M	$590M	$316M	$181M	$176M
Shares Outstanding	49,330,000	43,432,000	42,569,000	41,830,000	41,397,000	40,394,000	39,018,000	38,463,000	37,618,000	34,230,000	29,766,000	29,229,000

Fluxo de Caixa 19

Dados anuais de Fluxo de Caixa para AORT
Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
D&A	$22M	$24M	$23M	$22M	$24M	$21M	$18M	$18M	$10M	$8M	$6M	$6M
Stock-based Comp	$24M	$14M	$14M	$12M	$11M	$7M	$9M	$6M	$7M	$6M	$5M	$3M
Deferred Tax	$37.0K	$-2M	$-1M	$-885.0K	$-6M	$816.0K	$-2M	$-6M	$-1M	$3M	$1M	$173.0K
Amort. of Intangibles	$14M	$16M	$15M	$15M	$17M	$14M	$11M	$11M	$5M	$4M	$2M	$2M
Other Non-cash	$-17M	$-1M	$13M	$-20M	$-17M	$611.0K	$-11M	$-5M	$-8M	$-8M	·	$-9M
Operating Cash Flow	$40M	$22M	$19M	$-5M	$-3M	$12M	$16M	$10M	$11M	$20M	$11M	$8M
CapEx	$39M	$11M	$10M	$11M	$13M	$7M	$8M	$6M	$7M	$6M	$3M	$4M
Investing Cash Flow	$-42M	$-28M	$-502.0K	$-11M	$6M	$-73M	$-24M	$-7M	$-171M	$-79M	$-4M	·
Debt Issued	$0	$184M	$0	$0	·	·	·	·	·	·	·	·
Net Debt Issued	$-210.0K	$-28M	$-3M	·	·	·	·	·	·	·	·	·
Stock Issued	$13M	$6M	$4M	$3M	$4M	$2M	$5M	$4M	$3M	$2M	$2M	$3M
Stock Repurchased	·	·	·	·	·	·	·	·	·	·	·	$6M
Net Stock Activity	$13M	$6M	$4M	$3M	$4M	$2M	$5M	$4M	$3M	$2M	·	$-3M
Dividends Paid	·	·	·	·	·	·	·	·	·	·	$3M	$3M
Financing Cash Flow	$11M	$2M	$865.0K	$-2M	$-12M	$94M	$-1M	$-3M	$143M	$73M	$-3M	·
Net Change in Cash	$11M	$-5M	$20M	$-16M	$-7M	$28M	$-8M	$1M	$-17M	$14M	$4M	$-4M
Taxes Paid	$3M	·	·	·	·	·	·	·	·	·	$145.0K	$3M
Free Cash Flow	$839.0K	$11M	$11M	$-14M	$-16M	$5M	$8M	$4M	$4M	$14M	·	$4M
Levered FCF	·	·	$-25M	$-38M	$-33M	$-11M	$-8M	$-3M	$-925.8K	$12M	·	·

Lucratividade 8

Dados anuais de Lucratividade para AORT
Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Gross Margin	64.4%	64.0%	64.7%	64.5%	66.1%	66.3%	66.3%	65.8%	67.8%	65.9%	·	63.1%
Operating Margin	7.6%	10.0%	1.6%	2.0%	2.7%	0.96%	6.2%	3.5%	4.2%	12.1%	·	6.1%
Net Margin	2.2%	-3.4%	-8.7%	-6.1%	-5.0%	-6.6%	0.62%	-1.1%	1.9%	6.0%	·	5.1%
Pretax Margin	3.4%	-1.9%	-6.1%	-4.8%	-5.0%	-6.8%	0.60%	-2.4%	1.9%	10.2%	·	6.0%
EBITDA Margin	12.7%	16.2%	8.1%	9.1%	10.7%	9.1%	12.8%	10.4%	9.3%	16.7%	·	10.3%
ROA	1.2%	-1.7%	-4.0%	-2.5%	-1.9%	-2.4%	0.29%	-0.49%	0.82%	4.3%	·	4.2%
ROE	2.2%	-4.6%	-11.1%	-7.1%	-4.9%	-5.1%	0.61%	-1.0%	1.5%	5.9%	·	5.0%
ROIC	3.4%	11.7%	1.4%	1.3%	1.3%	0.38%	3.6%	0.84%	1.7%	4.5%	·	5.0%

Liquidez e Solvência 5

Dados anuais de Liquidez e Solvência para AORT
Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio	3.5	4.3	4.9	5.0	5.5	3.9	4.1	5.2	4.2	4.9	·	5.1
Quick Ratio	1.5	2.0	2.3	2.0	2.4	1.8	1.9	2.6	2.0	2.8	·	2.6
Debt / Equity	0.5	1.1	1.1	1.1	1.0	0.9	0.8	0.8	0.8	0.3	·	·
LT Debt / Equity	0.5	1.1	1.1	1.1	1.0	0.9	0.8	0.8	0.8	0.3	·	·
Interest Coverage	·	·	0.2	0.3	0.5	0.1	1.1	0.6	1.6	7.3	·	·

Eficiência 3

Dados anuais de Eficiência para AORT
Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover	0.5	0.5	0.5	0.4	0.4	0.4	0.5	0.5	0.4	0.7	·	0.8
Inventory Turnover	1.8	1.7	1.6	1.5	1.4	1.4	1.9	1.9	1.7	3.0	·	4.7
Receivables Turnover	5.2	5.1	5.3	5.5	6.0	5.1	5.5	5.6	5.0	7.0	·	7.4

Por Ação 7

Dados anuais de Por Ação para AORT
Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Book Value / Share	$9.09	$6.36	$6.62	$6.80	$7.26	$8.14	$7.32	$7.15	$7.37	$6.11	·	$5.09
Revenue / Share	$9.36	$9.32	$8.69	$7.84	$7.67	$6.69	$7.30	$7.22	$5.55	$5.50	·	$5.11
Cash Flow / Share	$0.85	$0.53	$0.46	$-0.13	$-0.07	$0.33	$0.42	$0.27	$0.32	$0.60	·	$0.29
Cash / Share	$1.32	$1.23	$1.38	$0.94	$1.33	$1.52	$0.87	$1.08	$1.06	$1.65	·	$1.14
Dividend / Share	·	·	·	·	·	·	$0	$0	$0	$0	$0	$0
Dividend Paid / Share	·	·	·	·	·	·	·	·	·	·	$0	$0
EPS (TTM)	$0.21	$-0.32	$-0.75	$-0.48	$-0.38	$-0.44	$0.05	$-0.08	$0.11	$0.32	$0.14	$0.25

Taxas de Crescimento 3

Dados anuais de Taxas de Crescimento para AORT
Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	13.6%	9.8%	12.8%	5.0%	18.0%	·	·	·	·	·	·	·
Revenue CAGR 3Y	12.0%	9.1%	11.8%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	11.8%	·	·	·	·	·	·	·	·	·	·	·

Avaliação (TTM) 17

Dados anuais de Avaliação (TTM) para AORT
Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$441M	$389M	$354M	$314M	$299M	$253M	$276M	$263M	$190M	$180M	$146M	$145M
Net Income TTM	$10M	$-13M	$-31M	$-19M	$-15M	$-17M	$2M	$-3M	$4M	$11M	$4M	$7M
Market Cap	$2.25B	$1.24B	$761M	$507M	$842M	$954M	$1.06B	$1.09B	$720M	$656M	·	$331M
Enterprise Value	$2.40B	$1.50B	$1.01B	$776M	$1.10B	$1.18B	$1.24B	$1.27B	$899M	$670M	·	·
P/E	217.2	-89.3	-23.8	-25.2	-53.6	-53.7	541.8	-354.8	174.1	59.8	77.0	45.3
P/S	5.1	3.2	2.2	1.6	2.8	3.8	3.8	4.2	3.8	3.6	·	2.3
P/B	5.0	4.5	2.7	1.8	2.8	2.9	3.7	4.0	2.6	3.1	·	2.2
P / Tangible Book	31.9	·	·	·	·	·	·	·	·	·	·	·
P / Cash Flow	56.4	55.8	40.4	-98.4	-325.9	77.1	66.8	110.5	66.7	33.2	·	40.8
P / FCF	2681.7	112.4	66.8	-35.8	-53.7	189.2	136.3	266.6	172.7	48.5	·	87.0
EV / EBITDA	42.7	23.8	35.0	27.1	34.2	51.1	35.0	46.2	50.8	22.2	·	·
EV / FCF	2860.7	136.0	88.6	-54.7	-70.0	234.9	159.8	309.4	215.6	49.6	·	·
EV / Revenue	5.4	3.9	2.9	2.5	3.7	4.7	4.5	4.8	4.7	3.7	·	·
Dividend Yield	·	·	·	·	·	·	·	·	·	·	·	0.99%
Earnings Yield	0.46%	-1.1%	-4.2%	-4.0%	-1.9%	-1.9%	0.18%	-0.28%	0.57%	1.7%	1.3%	2.2%
Payout Ratio	·	·	·	·	·	·	·	·	·	·	·	45.0%
Annual Payout	·	·	·	·	·	·	·	·	·	·	$3M	$3M

Demonstração de Resultados 18

Dados trimestrais de Demonstração de Resultados para AORT
Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$126M	$116M	$116M	$113M	$113M	$99M	$97M	$96M	$98M	$97M	$94M	$88M	$89M	$83M	$79M	$77M
Cost of Revenue	$45M	$41M	$43M	$39M	$40M	$35M	$36M	$35M	$35M	$34M	$33M	$32M	$31M	$30M	$29M	$28M
Gross Profit	$81M	$75M	$73M	$74M	$73M	$64M	$62M	$61M	$63M	$63M	$61M	$56M	$58M	$54M	$51M	$49M
R&D Expense	$9M	$9M	$9M	$8M	$7M	$7M	$7M	$7M	$7M	$7M	$8M	$6M	$7M	$7M	$8M	$12M
SG&A Expense	$80M	$61M	$57M	$57M	$58M	$55M	$51M	$50M	$49M	$31M	$50M	$51M	$57M	$50M	$38M	$41M
Operating Expenses	$89M	$70M	$66M	$65M	$65M	$61M	$59M	$57M	$57M	$38M	$58M	$58M	$65M	$58M	$47M	$53M
Operating Income	$-8M	$6M	$11M	$13M	$8M	$2M	$3M	$4M	$7M	$25M	$3M	$-1M	$8M	$-4M	$4M	$-4M
Interest Expense	·	·	·	·	·	·	·	·	·	$8M	·	$7M	$6M	$6M	·	$5M
Interest Income	$367.0K	$205.0K	$311.0K	$240.0K	$68.0K	$144.0K	$374.0K	$366.0K	$353.0K	$374.0K	$398.0K	$339.0K	$265.0K	$75.0K	$61.0K	$40.0K
Other Non-op	$4M	$-286.0K	$1M	$399.0K	$5M	$3M	$-10M	$2M	$-983.0K	$-1M	$2M	$-2M	$-4M	$963.0K	$4M	$-4M
Pretax Income	$-12M	$339.0K	$7M	$7M	$3M	$-2M	$-17M	$-1M	$-2M	$13M	$-591.0K	$-9M	$-3M	$-9M	$3M	$-13M
Income Tax	$2M	$-1M	$4M	$554.0K	$2M	$-2M	$-119.0K	$1M	$-306.0K	$5M	$3M	$382.0K	$725.0K	$5M	$1M	$1M
Net Income	$-14M	$1M	$2M	$7M	$1M	$-505.0K	$-16M	$-2M	$-2M	$8M	$-4M	$-10M	$-3M	$-14M	$2M	$-14M
EPS (Basic)	$-0.28	$0.03	$0.06	$0.14	$0.03	$-0.01	$-0.40	$-0.05	$-0.05	$0.18	$-0.10	$-0.24	$-0.08	$-0.33	$0.05	$-0.34
EPS (Diluted)	$-0.28	$0.03	$0.06	$0.13	$0.03	$-0.01	$-0.40	$-0.05	$-0.05	$0.18	$-0.10	$-0.24	$-0.08	$-0.33	$0.05	$-0.34
Shares (Basic)	48,541,000	48,074,000	-88,426,000	47,233,000	44,296,000	42,232,000	-83,141,000	41,844,000	41,683,000	41,290,000	-81,325,000	40,881,000	40,755,000	40,432,000	-79,964,000	40,115,000
Shares (Diluted)	48,541,000	49,731,000	-89,223,000	48,775,000	45,378,000	42,232,000	-89,737,000	41,844,000	41,683,000	47,886,000	-81,325,000	40,881,000	40,755,000	40,432,000	-79,964,000	40,115,000
EBITDA	$-8M	$12M	·	$13M	$8M	$8M	·	$4M	$7M	$31M	·	$-1M	$8M	$2M	·	$-4M

Balanço Patrimonial 26

Dados trimestrais de Balanço Patrimonial para AORT
Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$77M	$56M	$65M	$73M	$53M	$38M	$53M	$56M	$55M	$51M	·	$53M	$49M	$31M	·	$38M
Receivables	$98M	$92M	$90M	$88M	$91M	$88M	$79M	$76M	$74M	$74M	·	$64M	$65M	$63M	·	$57M
Inventory	$103M	$98M	$92M	$91M	$87M	$82M	$80M	$84M	$81M	$82M	·	$79M	$78M	$76M	·	$73M
Prepaid Expense	$27M	$45M	$43M	$22M	$25M	$20M	$19M	$19M	$20M	$17M	·	$17M	$19M	$20M	·	$17M
Current Assets	$371M	$358M	$358M	$337M	$319M	$287M	$290M	$288M	$285M	$277M	·	$267M	$264M	$241M	·	$238M
PP&E (Net)	$74M	$68M	$65M	$41M	$40M	$38M	$36M	$38M	$37M	$38M	·	$37M	$38M	$39M	·	$36M
Goodwill	$350M	$252M	$254M	$254M	$254M	$245M	$241M	$249M	$244M	$245M	$247M	$243M	$246M	$246M	$244M	$235M
Intangibles	$149M	$120M	$124M	$126M	$129M	$128M	$128M	$135M	$135M	$138M	·	$143M	$147M	$150M	·	$148M
Other Non-current Assets	$15M	$16M	$15M	$29M	$27M	$25M	$24M	$21M	$14M	$13M	·	$8M	$8M	$8M	·	$7M
Total Assets	$1.07B	$883M	$885M	$858M	$838M	$791M	$789M	$803M	$790M	$784M	·	$775M	$778M	$757M	·	$743M
Accounts Payable	$21M	$18M	$16M	$16M	$19M	$12M	$18M	$11M	$12M	$10M	·	$11M	$10M	$9M	·	$11M
Accrued Liabilities	$16M	$17M	$16M	$12M	$11M	$12M	$12M	$16M	$16M	$16M	·	$10M	$10M	$10M	·	$10M
Current Liabilities	$107M	$93M	$102M	$86M	$67M	$52M	$67M	$153M	$51M	$46M	·	$55M	$56M	$44M	·	$46M
Capital Leases	$36M	$34M	$34M	$38M	$39M	$39M	$40M	$41M	$42M	$43M	·	$43M	$40M	$41M	·	$41M
Deferred Tax	$26M	$28M	$24M	$22M	$23M	$22M	$20M	$19M	$22M	$22M	·	$20M	$19M	$24M	·	$34M
Other Non-current Liabilities	$9M	$9M	$9M	$9M	$9M	$8M	$8M	$8M	$8M	$8M	·	$8M	$7M	$7M	·	$7M
Total Liabilities	$626M	$433M	$437M	$419M	$418M	$497M	$513M	$498M	$494M	$489M	·	$503M	$495M	$477M	·	$488M
Long-term Debt	$363M	$215M	$215M	$215M	$216M	$315M	$314M	$314M	$314M	$313M	·	$307M	$308M	$308M	·	$308M
Total Debt	$363M	$215M	·	$215M	$216M	$315M	·	$314M	$314M	$313M	·	$307M	$308M	$308M	·	$308M
Common Stock	$502.0K	$500.0K	$493.0K	$488.0K	$486.0K	$442.0K	$434.0K	$434.0K	$433.0K	$432.0K	·	$425.0K	$424.0K	$424.0K	·	$418.0K
Retained Earnings	$-64M	$-50M	$-51M	$-54M	$-60M	$-62M	$-61M	$-45M	$-42M	$-40M	·	$-44M	$-34M	$-31M	·	$-19M
Treasury Stock	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	·	$15M	$15M	$15M	·	$15M
AOCI	$-12M	$-12M	$-3M	$-2M	$-3M	$-19M	$-25M	$-10M	$-16M	$-14M	·	$-21M	$-16M	$-18M	·	$-45M
Stockholders' Equity	$446M	$450M	$448M	$439M	$420M	$294M	$276M	$305M	$295M	$295M	$282M	$272M	$283M	$280M	$284M	$255M
Liabilities + Equity	$1.07B	$883M	$885M	$858M	$838M	$791M	$789M	$803M	$790M	$784M	·	$775M	$778M	$757M	·	$743M
Shares Outstanding	50,179,000	49,983,000	49,330,000	48,862,000	48,592,000	44,190,000	43,432,000	43,392,000	·	·	42,569,000	42,537,000	42,443,000	42,366,000	41,830,000	41,816,000

Fluxo de Caixa 16

Dados trimestrais de Fluxo de Caixa para AORT
Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$7M	$6M	$6M	$6M	$6M	$5M	$6M	$6M	$6M	$6M	$6M	$6M	$6M	$6M	$5M	$6M
Stock-based Comp	$8M	$8M	$4M	$6M	$6M	$8M	$3M	$4M	$4M	$3M	$4M	$3M	$4M	$3M	$3M	$3M
Deferred Tax	·	·	·	·	·	·	$3M	·	·	·	$6M	·	·	·	·	·
Amort. of Intangibles	$4M	$4M	$3M	$3M	$3M	$3M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M
Other Non-cash	·	$-15M	·	·	·	$-30M	·	·	·	$-22M	·	·	·	$-2M	·	·
Operating Cash Flow	$-1M	$1M	$20M	$22M	$15M	$-17M	$10M	$11M	$6M	$-5M	$11M	$7M	$7M	$-6M	$-217.0K	$4M
CapEx	$11M	$8M	$28M	$5M	$3M	$4M	$1M	$4M	$3M	$4M	$3M	$3M	$3M	$3M	$4M	$3M
Investing Cash Flow	$-129M	$-11M	$-31M	$-5M	$-3M	$-4M	$-11M	$-11M	$-3M	$-4M	$-3M	$-2M	$7M	$-3M	$-3M	$-3M
Debt Issued	·	·	$0	$0	$0	$0	$-6M	$160M	$160M	$190M	$0	$0	$0	$0	·	·
Net Debt Issued	·	$0	·	·	·	$-66.0K	·	·	·	$-182M	·	·	·	·	·	·
Stock Issued	$1M	$1M	$3M	$5M	$278.0K	$4M	$443.0K	$2M	$59.0K	$4M	$488.0K	$886.0K	$0	$3M	$24.0K	$1M
Net Stock Activity	·	$1M	·	·	·	$4M	·	·	·	$4M	·	·	·	$3M	·	·
Financing Cash Flow	$152M	$463.0K	$2M	$2M	$3M	$4M	$174.0K	$1M	$-181.0K	$737.0K	$-2M	$-909.0K	$2M	$1M	$-859.0K	$252.0K
Net Change in Cash	$22M	$-9M	$-9M	$20M	$16M	$-16M	$-3M	$1M	$4M	$-8M	$5M	$5M	$18M	$-9M	$2M	$-3M
Free Cash Flow	·	$-7M	·	·	·	$-21M	·	·	·	$-9M	·	·	·	$-8M	·	·
Levered FCF	·	·	·	·	·	·	·	·	·	$-14M	·	·	·	$-18M	·	·

Lucratividade 8

Dados trimestrais de Lucratividade para AORT
Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Gross Margin	64.0%	64.8%	·	65.6%	64.7%	64.2%	·	63.7%	64.6%	64.6%	·	64.0%	65.1%	64.5%	·	63.4%
Operating Margin	-6.7%	5.0%	·	11.1%	7.4%	2.2%	·	4.6%	6.6%	26.0%	·	-1.4%	8.6%	-4.6%	·	-5.3%
Net Margin	-10.7%	1.2%	·	5.7%	1.2%	-0.51%	·	-2.4%	-2.2%	7.7%	·	-11.2%	-3.8%	-16.3%	·	-17.8%
Pretax Margin	-9.3%	0.29%	·	6.2%	3.1%	-2.3%	·	-1.3%	-2.5%	13.1%	·	-10.7%	-3.0%	-10.7%	·	-16.3%
EBITDA Margin	-6.7%	10.4%	·	11.1%	7.4%	7.7%	·	4.6%	6.6%	32.0%	·	-1.4%	8.6%	2.2%	·	-5.3%
ROA	-1.4%	0.17%	·	0.78%	0.17%	-0.06%	·	-0.29%	-0.27%	0.98%	·	-1.3%	-0.44%	-1.8%	·	-1.8%
ROE	-3.1%	0.38%	·	1.8%	0.38%	-0.17%	·	-0.79%	-0.73%	2.6%	·	-3.7%	-1.2%	-4.7%	·	-4.8%
ROIC	-1.2%	3.6%	·	1.8%	0.51%	0.08%	·	1.3%	0.93%	2.5%	·	-0.22%	1.7%	-1.0%	·	-0.80%

Liquidez e Solvência 5

Dados trimestrais de Liquidez e Solvência para AORT
Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	3.5	3.9	·	3.9	4.8	5.5	·	1.9	5.6	6.0	·	4.9	4.7	5.5	·	5.2
Quick Ratio	1.6	1.6	·	1.9	2.2	2.4	·	0.9	2.5	2.7	·	2.1	2.0	2.1	·	2.1
Debt / Equity	0.8	0.5	·	0.5	0.5	1.1	·	1.0	1.1	1.1	·	1.1	1.1	1.1	·	1.2
LT Debt / Equity	0.8	0.5	·	0.5	0.5	1.1	·	0.7	1.1	1.1	·	1.1	1.1	1.1	·	1.2
Interest Coverage	·	·	·	·	·	·	·	·	·	3.2	·	-0.2	1.2	-0.6	·	-0.9

Eficiência 3

Dados trimestrais de Eficiência para AORT
Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1
Inventory Turnover	0.5	0.5	·	0.4	0.5	0.4	·	0.4	0.4	0.4	·	0.4	0.4	0.4	·	0.4
Receivables Turnover	1.3	1.3	·	1.4	1.4	1.2	·	1.4	1.4	1.4	·	1.4	1.5	1.4	·	1.4

Por Ação 5

Dados trimestrais de Por Ação para AORT
Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$8.88	$9.01	·	$8.98	$8.64	$6.66	·	$7.02	·	·	·	$6.39	$6.66	$6.61	·	$6.10
Revenue / Share	$2.59	$2.34	·	$2.32	$2.49	$2.34	·	$2.29	$2.35	$2.03	·	$2.15	$2.19	$2.06	·	$1.92
Cash Flow / Share	·	$0.02	·	·	·	$-0.40	·	·	·	$-0.11	·	·	·	$-0.15	·	·
Cash / Share	$1.54	$1.12	·	$1.50	$1.10	$0.85	·	$1.29	·	·	·	$1.26	$1.15	$0.73	·	$0.90
EPS (TTM)	$-0.09	$0.18	·	$0.10	$-0.08	$0.07	·	$-0.16	$-0.19	$-0.47	·	$-0.99	$-0.86	$-0.86	·	$-0.27

Avaliação (TTM) 14

Dados trimestrais de Avaliação (TTM) para AORT
Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$468M	$442M	·	$421M	$406M	$390M	·	$379M	$373M	$358M	·	$337M	$330M	$318M	·	$307M
Net Income TTM	$-4M	$9M	·	$5M	$-4M	$3M	·	$-7M	$-8M	$-19M	·	$-40M	$-35M	$-35M	·	$-11M
Market Cap	$1.13B	$1.83B	·	$2.07B	$1.51B	$1.09B	·	$1.16B	·	·	·	$645M	$730M	$555M	·	$579M
Enterprise Value	$1.41B	$1.99B	·	$2.21B	$1.67B	$1.36B	·	$1.41B	·	·	·	$899M	$988M	$832M	·	$849M
P/E	-249.7	203.4	·	423.4	-388.8	351.1	·	-166.4	-135.0	-45.0	·	-15.3	-20.0	-15.2	·	-51.3
P/S	2.4	4.1	·	4.9	3.7	2.8	·	3.0	·	·	·	1.9	2.2	1.7	·	1.9
P/B	2.5	4.1	·	4.7	3.6	3.7	·	3.8	·	·	·	2.4	2.6	2.0	·	2.3
P / Tangible Book	·	23.2	·	35.5	41.0	·	·	·	·	·	·	·	·	·	·	·
P / Cash Flow	·	1586.1	·	·	·	-64.1	·	·	·	·	·	·	·	-90.2	·	·
P / FCF	·	-267.2	·	·	·	-52.8	·	·	·	·	·	·	·	-66.1	·	·
EV / EBITDA	-169.0	164.1	·	176.3	199.6	179.6	·	322.1	·	·	·	-722.5	128.8	444.3	·	-206.9
EV / FCF	·	-290.5	·	·	·	-66.2	·	·	·	·	·	·	·	-99.2	·	·
EV / Revenue	3.0	4.5	·	5.2	4.1	3.5	·	3.7	·	·	·	2.7	3.0	2.6	·	2.8
Earnings Yield	-0.40%	0.49%	·	0.24%	-0.26%	0.28%	·	-0.60%	-0.74%	-2.2%	·	-6.5%	-5.0%	-6.6%	·	-1.9%

Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos

Demonstração de Resultados

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Receita	$441M	$389M	$354M	$314M	$299M
Margem Bruta %	64.4%	64.0%	64.7%	64.5%	66.1%
Margem Operacional %	7.6%	10.0%	1.6%	2.0%	2.7%
Lucro líquido	$10M	$-13M	$-31M	$-19M	$-15M
EPS Diluído	$0.21	$-0.32	$-0.75	$-0.48	$-0.38

Balanço Patrimonial

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dívida / Patrimônio Líquido	0.5	1.1	1.1	1.1	1.0
Índice de liquidez corrente	3.5	4.3	4.9	5.0	5.5
Índice de Liquidez Seca	1.5	2.0	2.3	2.0	2.4

Fluxo de Caixa

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Fluxo de caixa livre	$839.0K	$11M	$11M	$-14M	$-16M

Últimas notícias Notícias recentes mencionando esta empresa

Criando opções de título dentro das diretrizes editoriais An ETF Shop Just Made a Beaten-Down Medtech Its Top Holding Nasdaq · 3 meses atrás
Fortes Catalisadores Impulsionam a Artivion (AORT) Yahoo Finance · 3 meses, 3 semanas atrás

Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos

📊

Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.

Sua seleção é salva e acompanha você em todos os tickers.

Investidores institucionais (13F) 217 declarantes · $728.9M total · Em 30 de Junho de 2026

Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.

Atividade institucional — Q2 2026 vs trimestre anterior

Novas posições	Posições encerradas	Aumentou	Diminuído	Variação líquida de ações
42 (+7 vs trimestre anterior)	64 (+28 vs trimestre anterior)	80 (-7 vs trimestre anterior)	47 (-16 vs trimestre anterior)	+5.4M

Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.

Instituição	Valor	Ações	% de 13F rastreado	Tipo
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.	$71.566.000	3.184.974	9,82%	Ações
Juniper Investment Company, LLC	$45.386.816	2.019.885	6,23%	Ações
VANGUARD CAPITAL MANAGEMENT LLC	$45.043.789	2.004.619	6,18%	Ações
FMR LLC	$41.871.497	1.863.440	5,74%	Ações
STATE STREET CORP	$41.750.406	1.858.051	5,73%	Ações
Ophir Asset Management Pty Ltd	$40.446.180	1.800.008	5,55%	Ações
PERCEPTIVE ADVISORS LLC	$39.036.906	1.737.290	5,36%	Ações
Conestoga Capital Advisors, LLC	$36.484.539	1.623.700	5,01%	Ações
SILVERCREST ASSET MANAGEMENT GROUP LLC	$23.011.325	1.024.091	3,16%	Ações
VANGUARD PORTFOLIO MANAGEMENT LLC	$22.205.281	988.219	3,05%	Ações
GEODE CAPITAL MANAGEMENT, LLC	$21.427.261	953.365	2,94%	Ações
DIMENSIONAL FUND ADVISORS LP	$20.062.856	892.873	2,75%	Ações
CITADEL ADVISORS LLC	$17.701.821	787.798	2,43%	Ações
YARGER WEALTH STRATEGIES, LLC	$15.278.432	634.223	2,10%	Ações
ROYCE & ASSOCIATES LP	$14.364.667	639.282	1,97%	Ações
WELLINGTON MANAGEMENT GROUP LLP	$11.702.264	520.795	1,61%	Ações
Qube Research & Technologies Ltd	$10.704.820	476.405	1,47%	Ações
FRED ALGER MANAGEMENT, LLC	$10.406.104	463.111	1,43%	Ações
TWO SIGMA ADVISERS, LP	$9.974.907	218.700	1,37%	Ações
D. E. Shaw & Co., Inc.	$9.846.714	438.216	1,35%	Ações
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$9.183.579	408.704	1,26%	Ações
Toroso Investments, LLC	$9.018.146	197.723	1,24%	Ações
Soleus Capital Management, L.P.	$8.718.360	388.000	1,20%	Ações
TWO SIGMA INVESTMENTS, LP	$8.702.159	387.279	1,19%	Ações
Balyasny Asset Management L.P.	$8.584.686	382.051	1,18%	Ações
GOLDMAN SACHS GROUP INC	$7.733.095	344.152	1,06%	Ações
VANGUARD FIDUCIARY TRUST CO	$6.978.103	310.552	0,96%	Ações
KENNEDY CAPITAL MANAGEMENT LLC	$6.611.371	294.231	0,91%	Ações
UBS Group AG	$6.026.544	268.204	0,83%	Ações
WASATCH ADVISORS LP	$5.726.929	156.388	0,79%	Ações
BRIDGER MANAGEMENT, LLC	$4.855.373	132.588	0,67%	Ações
Quantinno Capital Management LP	$4.497.191	200.142	0,62%	Ações
AMERIPRISE FINANCIAL INC	$4.347.068	193.461	0,60%	Ações
FIFTH THIRD BANCORP	$4.170.912	185.621	0,57%	Ações
ORBIMED ADVISORS LLC	$3.932.250	175.000	0,54%	Ações
Corient Private Wealth LP	$3.578.618	159.262	0,49%	Ações
Public Sector Pension Investment Board	$3.298.304	146.787	0,45%	Ações
Parkman Healthcare Partners LLC	$3.121.982	138.940	0,43%	Ações
Universal- Beteiligungs- und Servicegesellschaft mbH	$2.879.149	128.133	0,40%	Ações
VOLORIDGE INVESTMENT MANAGEMENT, LLC	$2.857.263	127.159	0,39%	Ações
Summit Creek Advisors LLC	$2.704.354	120.354	0,37%	Ações
CONNORS INVESTOR SERVICES INC	$2.700.445	120.180	0,37%	Ações
BNP PARIBAS FINANCIAL MARKETS	$2.693.816	119.885	0,37%	Ações
Bank of New York Mellon Corp	$2.522.415	112.257	0,35%	Ações
RHUMBLINE ADVISERS	$2.373.280	105.621	0,33%	Ações
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$2.303.872	102.531	0,32%	Ações
XTX Topco Ltd	$2.173.905	96.747	0,30%	Ações
Swiss National Bank	$1.914.444	85.200	0,26%	Ações
BANK OF AMERICA CORP /DE/	$1.912.535	85.115	0,26%	Ações
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	$1.875.420	51.213	0,26%	Ações
LAZARD ASSET MANAGEMENT LLC	$1.875.301	83.458	0,26%	Ações
RENAISSANCE TECHNOLOGIES LLC	$1.524.073	67.827	0,21%	Ações
ALLIANCEBERNSTEIN L.P.	$1.522.477	41.575	0,21%	Ações
Legal & General Group Plc	$1.468.954	65.374	0,20%	Ações
CITIGROUP INC	$1.425.856	63.456	0,20%	Ações
Squarepoint Ops LLC	$1.424.238	63.384	0,20%	Ações
Russell Investments Group, Ltd.	$1.303.125	57.994	0,18%	Ações
VICTORY CAPITAL MANAGEMENT INC	$1.193.157	53.100	0,16%	Ações
ENVESTNET ASSET MANAGEMENT INC	$1.117.972	49.754	0,15%	Ações
Sterling Capital Management LLC	$1.098.918	48.906	0,15%	Ações
Sio Capital Management, LLC	$1.089.368	48.481	0,15%	Ações
BOOTHBAY FUND MANAGEMENT, LLC	$1.010.521	44.972	0,14%	Ações
PRUDENTIAL FINANCIAL INC	$995.219	44.291	0,14%	Ações
WELLS FARGO & COMPANY/MN	$937.314	41.714	0,13%	Ações
VANGUARD GROUP INC	$898.699	19.704	0,12%	Ações
FIRST TRUST ADVISORS LP	$857.657	38.169	0,12%	Ações
BlackRock, Inc.	$789.461	35.134	0,11%	Ações
Zurcher Kantonalbank (Zurich Cantonalbank)	$738.274	32.856	0,10%	Ações
Verition Fund Management LLC	$729.399	32.461	0,10%	Ações
Aquatic Capital Management LLC	$712.771	31.721	0,10%	Ações
Jain Global LLC	$680.908	30.303	0,09%	Ações
JONES FINANCIAL COMPANIES LLLP	$662.072	28.042	0,09%	Ações
Brevan Howard Capital Management LP	$652.461	29.037	0,09%	Ações
VANGUARD ASSET MANAGEMENT, Ltd	$634.193	28.224	0,09%	Ações
JANUS HENDERSON GROUP PLC	$623.335	17.038	0,09%	Ações
MetLife Investment Management, LLC	$601.050	26.749	0,08%	Ações
Y-Intercept (Hong Kong) Ltd	$600.735	26.735	0,08%	Ações
Mariner, LLC	$570.520	25.390	0,08%	Ações
TOCQUEVILLE ASSET MANAGEMENT L.P.	$561.750	25.000	0,08%	Ações
Illinois Municipal Retirement Fund	$545.010	24.255	0,07%	Ações
MANUFACTURERS LIFE INSURANCE COMPANY, THE	$516.855	23.002	0,07%	Ações
Walleye Capital LLC	$490.408	21.825	0,07%	Ações
Penn Capital Management Company, LLC	$489.689	21.793	0,07%	Ações
ALLSTATE CORP	$483.240	21.506	0,07%	Ações
EXCHANGE TRADED CONCEPTS, LLC	$476.948	21.226	0,07%	Ações
MORGAN STANLEY	$476.588	21.210	0,07%	Ações
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	$473.241	21.061	0,06%	Ações
Louisiana State Employees Retirement System	$420.189	18.700	0,06%	Ações
Invesco Ltd.	$409.628	18.230	0,06%	Ações
DARK FOREST CAPITAL MANAGEMENT LP	$402.123	17.896	0,06%	Ações
Vanguard Global Advisers, LLC	$371.384	16.528	0,05%	Ações
Freestone Grove Partners LP	$328.219	14.607	0,05%	Ações
NEW YORK STATE COMMON RETIREMENT FUND	$324.287	14.432	0,04%	Ações
JOHNSON INVESTMENT COUNSEL INC	$307.008	13.663	0,04%	Ações
Police & Firemen's Retirement System of New Jersey	$303.053	13.487	0,04%	Ações
DIKER MANAGEMENT LLC	$303.000	13.500	0,04%	Ações
OPPENHEIMER ASSET MANAGEMENT INC.	$284.672	12.669	0,04%	Ações
GUGGENHEIM CAPITAL LLC	$283.302	12.608	0,04%	Ações
ELEVATION POINT WEALTH PARTNERS, LLC	$263.303	11.718	0,04%	Ações
Vestmark Advisory Solutions, Inc.	$263.303	11.718	0,04%	Ações

Executivos da empresa 49 insiders · 27 diretores · 15 conselheiros

Investidor com informação privilegiada	Função	Última atividade	Ações detidas	Vendas 12m	Líquido 12m
James P Mackin	President & CEO	6 de Março de 2025 M	865.283	0	$0
David Ashley Lee	Executive VP, COO & CFO	2 de Março de 2023 S	347.217	0	$0
Marshall S. Stanton	SVP, Clinical & MD Affair	17 de Junho de 2025 S	64.200	0	$0
John E Davis	Chief Commercial Officer	11 de Março de 2025 M	208.778	0	$0
Amy Horton	VP, Chief Accounting Officer	6 de Março de 2025 S	146.651	0	$0
Matthew A Getz	VP, Human Resources	16 de Agosto de 2024 S	34.116	0	$0
Florian Tyrs	VP, Global Operations	27 de Fevereiro de 2024 S	21.558	0	$0
Rochelle L. Maney	VP, Quality	26 de Fevereiro de 2024 S	44.518	0	$0
Robert C Thomson	VP Research & Development	23 de Fevereiro de 2024 A	13.291	0	$0
Dennis B Maier	SVP, Operations	6 de Junho de 2023 S	34.724	0	$0
Franz Peter Barthold	VP, Research & Development	8 de Novembro de 2022 A	32.516	0	$0
Scott B Capps	VP, Clinical Research	12 de Março de 2021 F	153.203	0	$0
James M Mcdermid	SVP, CHRO	14 de Março de 2019 F	30.806	0	$0
Sherry M Saurini	VP, Quality	14 de Março de 2019 F	25.084	0	$0
William Robert Matthews	Senior VP, Operations, Quality	5 de Março de 2018 F	39.883	0	$0
David C Gale	VP, Research & Development	16 de Novembro de 2017 M	77.135	0	$0
Steven G Anderson	Former Executive Chairman	9 de Abril de 2015 F	1.271.846	0	$0
Bruce G. Anderson	VP, US Sales &Global Marketing	7 de Março de 2015 F	42.106	0	$0
FRONK DAVID	VP, Regulatory Affairs	7 de Março de 2015 F	110.559	0	$0
David P. Lang	VP, Int'l Sales & Marketing	26 de Fevereiro de 2015 A	73.441	0	$0
Jeffrey W Burris	Vice President & Gen. Counsel	15 de Agosto de 2014 M	95.221	0	$0
Gerald B Seery	Sr. VP, Sales and Marketing	30 de Novembro de 2012 S	71.999	0	$0
Albert E Heacox	Sr. VP Research and Devl	31 de Dezembro de 2011 F	110.144	0	$0
Philip A Theodore	VP, General Counsel	4 de Setembro de 2007 A	23.100	0	$0
Sidney B Ashmore	Vice President of Marketing	18 de Janeiro de 2006 M	42.728	0	$0
Kirby S Black	Sr. Vice President, R&D	21 de Setembro de 2004 M	55.131	0	$0
Vander James C Wyk	VP - Product Integrity	14 de Setembro de 2004 M	36.165	0	$0
Anthony B. Semedo	Conselheiro	2 de Junho de 2026 J	6.325	0	$0
Elizabeth A Hoff	Conselheiro	22 de Maio de 2025 A	31.389	0	$0
Marna P Borgstrom	Conselheiro	22 de Maio de 2025 A	49.088	0	$0
Jon W Salveson	Conselheiro	22 de Maio de 2025 A	129.840	0	$0
Jeffrey H Burbank	Conselheiro	22 de Maio de 2025 A	53.796	0	$0
Daniel J Bevevino	Conselheiro	22 de Maio de 2025 A	150.061	0	$0
Bullock James	Conselheiro	22 de Maio de 2025 A	68.647	0	$0
Thomas F Ackerman	Conselheiro	22 de Maio de 2025 A	149.896	0	$0
Harvey Morgan	Conselheiro	30 de Agosto de 2021 G	46.342	0	$0
Ronald D Mccall	Conselheiro	25 de Agosto de 2021 S	121.768	0	$0
Elkins C Ronald	Conselheiro	5 de Setembro de 2018 S	64.843	0	$0
James Benson	Conselheiro	2 de Outubro de 2017 S	54.086	0	$0
John M Cook	Conselheiro	9 de Junho de 2009 M	85.000	0	$0
LACY VIRGINIA C	Conselheiro	24 de Abril de 2007 S	255.280	0	$0
VAN DYNE BRUCE J MD	Conselheiro	1 de Agosto de 2006 A	12.800	0	$0
OSS CAPITAL MANAGEMENT	Detentor de 10%	31 de Maio de 2007 S	1.918.000	0	$0
Lance A Berry	—	14 de Agosto de 2026 S	210.112	1	$-20.413
Andrew M Green	—	14 de Agosto de 2026 S	59.643	3	$-928.248
Jean F Holloway	—	12 de Agosto de 2026 S	184.118	1	$-27.835
Michael S Simpson	—	5 de Março de 2021 F	33.698	0	$0
Thomas J Bogenschuetz	—	5 de Maio de 2020 A	23.451	0	$0
Thomas J Lynch	—	2 de Novembro de 2004 A	5.000	0	$0

Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto

Ativistas e proprietários de 5%+ 5 participações

Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.

Declarante	Declarado	Participação	Status	Propósito	Declaração
Juniper Targeted Opportunity Fund, L.P., Juniper HF Investors II, LLC, Juniper Targeted Opportunities, L.P., Juniper Targeted Opportunity Investors, LLC, Juniper Multi-Strategy Fund, L.P., Juniper HF Investors, LLC, Juniper Investment Company, LLC, Alexis P. Michas, John A. Bartholdson ×2 declarações	12 de Agosto de 2025	4,00%	Emenda	—	SEC
CryoLife, Inc., CL Falcon, Inc.	11 de Maio de 2011	—	Declaração inicial	M&A / venda	SEC
Michael A. Roth and Brian J. Stark, as joint filers pursuant to Rule 13d-1(k)	10 de Julho de 2007	—	Declaração inicial	—	SEC
Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada	2 de Dezembro de 2005	—	Declaração inicial	Investimento passivo	SEC
Pessoa de relato não divulgada	18 de Março de 2005	—	Declaração inicial	Investimento passivo	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Participação em ETFs Detido por 53 ETFs

O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.

Fundo	Peso	Unidades	Em	Fonte
SAWS · ETF Series Solutions	2,95%	5.817 NS	30 de Abril de 2026	N-PORT
HTEC · EXCHANGE TRADED CONCEPTS TRUST	1,77%	26.421 NS	30 de Abril de 2026	N-PORT
PSCH · Invesco Exchange-Traded Fund Trust …	0,59%	37.075 SH	8 de Agosto de 2026	Diário
RZG · Invesco Exchange-Traded Fund Trust	0,44%	22.725 SH	8 de Agosto de 2026	Diário
SIXL · EXCHANGE TRADED CONCEPTS TRUST	0,25%	21.547 NS	31 de Maio de 2026	N-PORT
ESSC · Strategy Shares	0,24%	1.691 NS	30 de Abril de 2026	N-PORT
XSMO · Invesco Exchange-Traded Fund Trust	0,21%	246.008 SH	8 de Agosto de 2026	Diário
IHI · iShares Trust	0,16%	202.161 SH	8 de Agosto de 2026	Diário
IJT · iShares Trust	0,13%	397.869 SH	8 de Agosto de 2026	Diário
FYC · First Trust Exchange-Traded AlphaDE…	0,11%	31.285 NS	30 de Abril de 2026	N-PORT
VIOG · VANGUARD ADMIRAL FUNDS	0,10%	50.848 SH	8 de Agosto de 2026	Diário
QVMS · Invesco Exchange-Traded Fund Trust …	0,08%	7.285 SH	8 de Agosto de 2026	Diário
IWO · iShares Trust	0,08%	419.028 SH	8 de Agosto de 2026	Diário
XJR · iShares Trust	0,07%	5.059 SH	8 de Agosto de 2026	Diário
IJR · iShares Trust	0,06%	2.606.468 SH	8 de Agosto de 2026	Diário
VTWG · VANGUARD SCOTTSDALE FUNDS	0,06%	49.054 SH	8 de Agosto de 2026	Diário
VIOO · VANGUARD ADMIRAL FUNDS	0,05%	148.966 SH	8 de Agosto de 2026	Diário
RSSL · Global X Funds	0,05%	18.968 NS	30 de Abril de 2026	N-PORT
SAA · ProShares Trust	0,04%	505 NS	31 de Maio de 2026	N-PORT
DFAS · Dimensional ETF Trust	0,04%	158.121 NS	30 de Abril de 2026	N-PORT
IWM · iShares Trust	0,04%	1.162.604 SH	8 de Agosto de 2026	Diário
ISCG · iShares Trust	0,04%	14.407 SH	8 de Agosto de 2026	Diário
RWJ · Invesco Exchange-Traded Fund Trust …	0,04%	28.917 SH	8 de Agosto de 2026	Diário
GSSC · Goldman Sachs ETF Trust	0,03%	14.525 NS	31 de Maio de 2026	N-PORT
EBIT · Harbor ETF Trust	0,03%	101 NS	30 de Abril de 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0,03%	263.046 SH	8 de Agosto de 2026	Diário
SMDX · Tidal Trust III	0,03%	999 NS	30 de Abril de 2026	N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust	0,03%	27.103 SH	8 de Agosto de 2026	Diário
ITWO · ProShares Trust	0,02%	2.057 NS	31 de Maio de 2026	N-PORT
FHLC · FIDELITY COVINGTON TRUST	0,02%	18.392 NS	30 de Abril de 2026	N-PORT
FAD · First Trust Exchange-Traded AlphaDE…	0,02%	2.917 NS	30 de Abril de 2026	N-PORT
SCHA · SCHWAB STRATEGIC TRUST	0,02%	200.917 NS	31 de Maio de 2026	N-PORT
ISCB · iShares Trust	0,02%	2.111 SH	8 de Agosto de 2026	Diário
UWM · ProShares Trust	0,01%	1.609 NS	31 de Maio de 2026	N-PORT
URTY · ProShares Trust	0,01%	1.624 NS	31 de Maio de 2026	N-PORT
JSTC · Tidal Trust I	0,01%	1.526 NS	31 de Maio de 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,01%	495.296 SH	8 de Agosto de 2026	Diário
VHT · VANGUARD WORLD FUND	0,01%	127.662 SH	8 de Agosto de 2026	Diário
WSML · iShares Trust	0,01%	2.264 SH	8 de Agosto de 2026	Diário
DFAC · Dimensional ETF Trust	0,01%	107.410 NS	30 de Abril de 2026	N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS	0,01%	1.773 NS	31 de Maio de 2026	N-PORT
DCOR · Dimensional ETF Trust	0,00%	3.861 NS	30 de Abril de 2026	N-PORT
HDG · ProShares Trust	0,00%	41 NS	31 de Maio de 2026	N-PORT
DFSU · Dimensional ETF Trust	0,00%	1.937 NS	30 de Abril de 2026	N-PORT
DFAU · Dimensional ETF Trust	0,00%	8.873 NS	30 de Abril de 2026	N-PORT
DFUS · Dimensional ETF Trust	0,00%	12.377 NS	30 de Abril de 2026	N-PORT
ITOT · iShares Trust	0,00%	61.883 SH	8 de Agosto de 2026	Diário
IWV · iShares Trust	0,00%	10.738 SH	8 de Agosto de 2026	Diário
SCHB · SCHWAB STRATEGIC TRUST	0,00%	25.635 NS	31 de Maio de 2026	N-PORT
TILT · FlexShares Trust	0,00%	636 NS	30 de Abril de 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0,00%	1.463.340 SH	8 de Agosto de 2026	Diário
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	3.652 SH	8 de Agosto de 2026	Diário
EBI · RBB Fund Trust	0,00%	3 NS	31 de Maio de 2026	N-PORT

Sobre Artivion, Inc. Common Stock Visão geral da empresa da Wikipedia

AORT Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas

AORT Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização

Médias móveis e sobreposições

Volume

Osciladores

Momento e tendência

Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS

Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?

Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC

Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial

Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos

Métricas por Ação EPS, valor patrimonial por ação, fluxo de caixa por ação, dividendo por ação

Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber

Dividendos Rendimento, índice de pagamento, histórico de dividendos, CAGR de 5 anos

AORT Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta

Preço-alvo de 12 meses

Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados

Comparação de pares (subindústria GICS) Métricas chave vs pares do setor

Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa

Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos

Últimas notícias Notícias recentes mencionando esta empresa

Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos

Investidores institucionais (13F) 217 declarantes · $728.9M total · Em 30 de Junho de 2026

Executivos da empresa 49 insiders · 27 diretores · 15 conselheiros

Ativistas e proprietários de 5%+ 5 participações

Participação em ETFs Detido por 53 ETFs